Adverum Biotechnologies Inc (NASDAQ:ADVM) traded at $1.77 at close of the session on Monday, March 18, made an upward move of 4.12% on its previous day’s price.
Looking at the stock we see that its previous close was $1.70 and the beta (5Y monthly) reads 0.87 . In terms of its 52-week price range, ADVM has a high of $2.97 and a low of $0.68. The company’s stock has lost about -11.50% over that past 30 days.
Adverum Biotechnologies Inc has a market cap of $366.67 million and is expected to release its quarterly earnings report on May 09, 2024 – May 13, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.34, with the EPS growth for the year raised at -$1.26 for 2023 and -$0.86 for next year. These figures represent 19.20% and 31.70% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ADVM stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is -7.48% off its SMA20 and 14.51% from its 50-day simple moving average. The RSI (14) is pointing at 48.87 while the volatility over the past week is 7.45% and jumps to 8.98% over the past one month. The beta value is 0.87, while the average true range (ATR) is currently pointing at 0.19.
Coming back to Adverum Biotechnologies Inc (NASDAQ:ADVM), we note that the average 3-month trading volume was 2.08 million, while that of the preceding 10-day period stands at 2.0 million. Current shares outstanding are 207.16 million.
The insiders hold 27.90% of the company’s shares while institutions hold 33.33%. The data shows that short shares as of Feb 29, 2024, stood at 5.43 million at a short ratio of 1.39. This represents a 2.62% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 1.22 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 135.12% up in year-to-date price movement.
